Classes of financial liabilities [axis] Classes of financial liabilities [axis] Accumulated Amortization Accumulated amortization Accumulated depreciation and amortisation [member] Types of share-based payment arrangements [axis] Types of share-based payment arrangements [axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Granted to employees Granted To Employees [Member] Granted To Employees Percentage of outstanding common shares Percentage Of Outstanding Common Shares Own Percentage Of Outstanding Common Shares Own Cover [Abstract] Expected dividend yield Expected Dividend As Percentage, Other Equity Instruments Granted Expected Dividend As Percentage, Other Equity Instruments Granted Proceeds from issue of ordinary shares Proceeds from issue of ordinary shares Disclosure of detailed information about business combination [line items] Disclosure of detailed information about business combination [line items] Common shares exchange rate Common Shares, Exchange Rate Common Shares, Exchange Rate Total Liabilities Current liabilities Current liabilities Number of warrants with extended expiry dates (in shares) Number Of Other Equity Instruments In Share-Based Payment Arrangement, Expiry Date Extended Number Of Other Equity Instruments In Share-Based Payment Arrangement, Expiry Date Extended Trading Symbol Trading Symbol Statement of changes in equity [abstract] Exercisable period Share-Based Compensation Arrangement, Expiration Period Share-Based Compensation Arrangement, Expiration Period GOODWILL Disclosure of goodwill [text block] Right of use asset Right Of Use Asset Recognised As Of Acquisition Date Right Of Use Asset Recognised As Of Acquisition Date Schedule of Financial Liabilities Disclosure of financial liabilities [text block] Financial assets, measured at amortized cost: Financial assets at amortised cost, category [member] Common shares Ordinary shares [member] Classes of intangible assets other than goodwill [domain] Classes of intangible assets other than goodwill [domain] Classes of intangible assets and goodwill [axis] Classes of intangible assets and goodwill [axis] Geographical areas [domain] Geographical areas [domain] Summary of number and weighted average exercise prices of share options Disclosure of number and weighted average exercise prices of share options [text block] Option Expiration Period Twenty Four And Thirty Option Expiration Period Twenty Four And Thirty [Member] Option Expiration Period Twenty Four And Thirty Option Expiration Period Twenty Four Option Expiration Period Twenty Four [Member] Option Expiration Period Twenty Four Number of Warrants Warrants, Number of Shares [Roll Forward] Warrants, Number of Shares Debt instrument, default rate Debt Instrument, Default Rate Debt Instrument, Default Rate Current assets Current assets recognised as of acquisition date Audited Annual Financial Statements Audited Annual Financial Statements Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location Lease liability Lease Liabilities Recognised As Of Acquisition Date Lease Liabilities Recognised As Of Acquisition Date Number of other equity instruments exercised or vested in share-based payment arrangement Exercised (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement Basis of consolidation Disclosure Of Basis Of Consolidation [Policy Text Block] Disclosure Of Basis Of Consolidation Cybin IRL Cybin IRL Limited [Member] Cybin IRL Limited Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Adjustment for fractional shares upon share consolidation (in shares) Increase (Decrease) Through Share Consolidation, Equity Increase (Decrease) Through Share Consolidation, Equity RESEARCH EXPENSES Disclosure of research and development expense [text block] August 4, 2028 Warrant Expiration Period One [Member] Warrant Expiration Period One Option Expiration Period Thirteen Option Expiration Period Thirteen [Member] Option Expiration Period Thirteen Types of risks [domain] Types of risks [domain] Sales royalty percentage Sales Royalty, Percentage Sales Royalty, Percentage Components of equity [domain] Components of equity [domain] United States UNITED STATES Warrant Expiration Period [Domain] Warrant Expiration Period [Domain] Warrant Expiration Period [Domain] Lease interest accretion Adjustment For Lease Interest Adjustment For Lease Interest Option Expiration Period Fourteen Option Expiration Period Fourteen [Member] Option Expiration Period Fourteen Schedule of subsidiaries and functional currencies Detail Description Of Functional Currencies [Table Text Block] Detail Description Of Functional Currencies Discount rate Discount rate, measurement input [member] OTHER INCOME (EXPENSES) Miscellaneous Income (Expense) [Abstract] Miscellaneous Income (Expense) Expected recovery at statutory rate Tax expense (income) at applicable tax rate SUBSEQUENT EVENTS Disclosure of non-adjusting events after reporting period [text block] Serenity Serenity [Member] Serenity Significant unobservable input, assets Significant unobservable input, assets 2041 2041 [Member] 2041 Deferred tax assets Gross Deferred Tax Assets Gross Deferred Tax Assets Disclosure of maturity analysis of operating lease payments [table] Disclosure of maturity analysis of operating lease payments [table] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Share Options, Vesting, Third Tranche Share Options, Vesting, Third Tranche [Member] Share Options, Vesting, Third Tranche Award vesting period Vesting Requirements For Share-Based Payment Arrangement, Vesting Period Vesting Requirements For Share-Based Payment Arrangement, Vesting Period Other loss Adjustments For Other Losses (Gains) Adjustments For Other Losses (Gains) Professional and consulting fees Professional And Consulting Fees Professional And Consulting Fees Interest income Interest income Number of share options forfeited in share-based payment arrangement Number of share options forfeited in share-based payment arrangement Number of share options forfeited/expired in share-based payment arrangement (in shares) Number Of Share Options Forfeited And Expired In Share-Based Payment Arrangement Number Of Share Options Forfeited And Expired In Share-Based Payment Arrangement Depreciation and amortization Adjustments for depreciation and amortisation expense Expected life (in years) Option life, share options granted Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Geographical [Axis] Geographical [Axis] Share-based compensation Expense from share-based payment transactions Weighted average remaining life Weighted average remaining contractual life of outstanding share options Cybin Corp. Cybin Corp [Member] Cybin Corp Depreciation charge Depreciation, property, plant and equipment Option Expiration Period Sixteen Option Expiration Period Sixteen [Member] Option Expiration Period Sixteen LIABILITIES Liabilities [abstract] Share issuance on business acquisition Increase (decrease) through acquisition of subsidiary, equity Option Expiration Period Thirty Option Expiration Period Thirty [Member] Option Expiration Period Thirty Summary of significant unobservable inputs used, equity Disclosure of significant unobservable inputs used in fair value measurement of equity [text block] Computer Equipment Computer equipment [member] INCOME TAX Disclosure of income tax [text block] Risk-free interest rate Risk Free Interest Rate, Other Equity Instruments Granted Risk Free Interest Rate, Other Equity Instruments Granted Classes of intangible assets and goodwill [domain] Classes of intangible assets and goodwill [domain] Cybin UK Ltd. Cybin UK Ltd. [Member] Cybin UK Ltd. Net cash flows provided by (used in) investing activities Cash flows from (used in) investing activities Share Capital, Reserves, and Other Equity Interest [Abstract] Share Capital, Reserves, and Other Equity Interest [Abstract] Types of risks [axis] Types of risks [axis] Share issuance on business acquisition (in shares) Number Of Shares Issued Through Acquisition Of Subsidiary, Equity Number Of Shares Issued Through Acquisition Of Subsidiary, Equity Reduction in interest income due to interest rate decline Interest Rate Risk, Increase (Decrease) In Interest Income Interest Rate Risk, Increase (Decrease) In Interest Income Financial Instruments [Abstract] Financial Instruments [Abstract] Period to exercise warrant Period To Exercise Warrants In Share-Based Payment Arrangement Period To Exercise Warrants In Share-Based Payment Arrangement Weighted average remaining of outstanding contractual life Weighted Average Remaining Contractual Life of Other Equity Instruments Weighted Average Remaining Contractual Life of Other Equity Instruments 2043 2043 [Member] 2043 2038 2038 [Member] 2038 Related Party [Abstract] Related Party Disclosure [Abstract] Outstanding (in shares) Outstanding (in shares) Warrants outstanding (in shares) Number of other equity instruments outstanding in share-based payment arrangement Equipment write-down Impairment loss recognised in profit or loss, property, plant and equipment Option Expiration Period Ten Option Expiration Period Ten [Member] Option Expiration Period Ten Summary of measurement of stock option fair value assumptions Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block] Warrants expired Increase (Decrease) Through Expiration Of Warrants, Equity Increase (Decrease) Through Expiration Of Warrants, Equity Statement of changes in equity [line items] Statement of changes in equity [line items] Unvested forfeiture rate Unvested Forfeiture Rate, As Percentage, Share Options Granted Unvested Forfeiture Rate, As Percentage, Share Options Granted Outstanding (in CAD per share) Outstanding (in CAD per share) Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement Statement of cash flows [abstract] Document Registration Statement Document Registration Statement Proceeds on exercise of warrants Proceeds from exercise of warrants Share consolidation, shares issued previously (in shares) Ordinary Shares, Consolidation, Shares Issued Previously Ordinary Shares, Consolidation, Shares Issued Previously Security Exchange Name Security Exchange Name Lease liabilities Lease liabilities [member] Weighted average exercise price, beginning balance (in dollars per share) Weighted average exercise price, ending balance (in dollars per share) Weighted average exercise price of share options outstanding in share-based payment arrangement ASSETS Assets [abstract] Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items] Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items] Lease liabilities, beginning of period Lease liabilities, end of period Lease liabilities Option Expiration Period Five Option Expiration Period Five [Member] Option Expiration Period Five Statement of financial position [abstract] Disclosure of detailed information about intangible assets [table] Disclosure of detailed information about intangible assets [table] Unit Purchase Warrants Unit Purchase Warrants [Member] Unit Purchase Warrants Options forfeited/expired Increase (Decrease) Through Share Options Forfeited And Expired In Share Based Payment Award, Equity Increase (Decrease) Through Share Options Forfeited And Expired In Share Based Payment Award, Equity Components of equity [axis] Components of equity [axis] Acquisition from Small Pharma Acquisitions through business combinations, property, plant and equipment Additions Additions To Lease Liabilities Additions To Lease Liabilities Difference between Canadian and foreign tax rates Tax effect of foreign tax rates Items of contingent liabilities [domain] Items of contingent liabilities [domain] Non-capital loss acquired on acquisition of subsidiary Increase (decrease) in amount recognised for pre-acquisition deferred tax asset Entity Addresses [Table] Entity Addresses [Table] ACQUISITION Disclosure of business combinations [text block] Temporary difference, unused tax losses and unused tax credits [domain] Temporary difference, unused tax losses and unused tax credits [domain] Weighted average exercise price Warrants, Weighted Average Exercise Price [Roll Forward] Warrants, Weighted Average Exercise Price Common Share Purchase Warrants Common Share Purchase Warrants [Member] Common Share Purchase Warrants Disclosure of Monetary Assets and Liabilities Currency Risk Fluctuations Disclosure of nature and extent of risks arising from financial instruments [text block] Accounts receivable Trade and other current receivables Effect of foreign exchange Effect Of Foreign Exchange, Lease Liabilities Effect Of Foreign Exchange, Lease Liabilities Number of share options granted in share-based payment arrangement (in shares) Number of share options granted in share-based payment arrangement Number of instruments or interests issued or issuable (in shares) Number of instruments or interests issued or issuable Schedule of goodwill Disclosure of reconciliation of changes in goodwill [text block] Net cash flows used in operating activities Cash flows from (used in) operating activities Cash flows from (used in) operating activities Share-based compensation Increase (decrease) through share-based payment transactions, equity Unobservable inputs [axis] Unobservable inputs [axis] Warrant Expiration Period [Axis] Warrant Expiration Period [Axis] Warrant Expiration Period Number of shares subject to resale restrictions (in shares) Number Of Shares Subject To Resale Restrictions Number Of Shares Subject To Resale Restrictions Schedule of lease liabilities Disclosure of maturity analysis of operating lease payments [text block] Adjustments for items not affecting cash: Adjustments to reconcile profit (loss) [abstract] Non-adjusting events after reporting period [axis] Non-adjusting events after reporting period [axis] March 2024 private placement March 2024 Private Placement [Member] March 2024 Private Placement Shares available for grant, percent of total shares outstanding (up to) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant, Percent Of Total Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant, Percent Of Total Shares Outstanding Share issuance costs Share issue related cost Expected annual volatility, based on historical share price of the Company Expected volatility, share options granted Disclosure of classes of share capital [table] Disclosure of classes of share capital [table] Reasonably possible change in risk variable, impact on net loss Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Impact On Profit (Loss) Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Impact On Profit (Loss) Professional and consulting fees Professional fees expense Contact Personnel Name Contact Personnel Name Events after reporting period [Abstract] Events after reporting period [Abstract] Option Expiration Period Eight Option Expiration Period Eight [Member] Option Expiration Period Eight Disclosure of detailed information about business combination [table] Disclosure of detailed information about business combination [table] Right-of-use asset Right-of-use assets, beginning of period Right-of-use assets, end of period Right-of-use assets Option Expiration Period Thirty Seven Option Expiration Period Thirty Seven [Member] Option Expiration Period Thirty Seven Share Options, Vesting, Fifth Tranche Share Options, Vesting, Fifth Tranche [Member] Share Options, Vesting, Fifth Tranche FINANCIAL INSTRUMENTS Disclosure of financial instruments [text block] Computer software Software Computer software [member] Option Expiration Period Thirty Five Option Expiration Period Thirty Five [Member] Option Expiration Period Thirty Five CAPITAL MANAGEMENT Disclosure of objectives, policies and processes for managing capital [text block] Entity Address, Country Entity Address, Country Accumulated other comprehensive loss Accumulated other comprehensive income [member] Unrealized foreign currency translation gain Adjustments For Unrealized Gain (Loss) On Foreign Currency Translation Adjustments For Unrealized Gain (Loss) On Foreign Currency Translation Entity Addresses [Line Items] Entity Addresses [Line Items] Share price (in CAD/USD per share) Share price (in USD per share) Share Price per Common Share Share Price per Common Share Document Fiscal Period Focus Document Fiscal Period Focus November 15, 2030 Warrant Expiration Period Five [Member] Warrant Expiration Period Five At-the-market offering - net of share issuance costs (in shares) Number Of Shares Issued Through Share Offering, Equity Number Of Shares Issued Through Share Offering, Equity Schedule of Financial Assets Disclosure of financial assets [text block] Cost Gross carrying amount [member] Disclosure of Financial Assets and Liabilities [Line Items] Disclosure of Financial Assets and Liabilities [Line Items] Disclosure of Financial Assets and Liabilities [Line Items] SHARE CAPITAL Disclosure of share capital, reserves and other equity interest [text block] Loss on derecognition of right-of-use assets Gain (Loss) On Derecognition of Right-Of-Use Assets Gain (Loss) On Derecognition of Right-Of-Use Assets Document Type Document Type Disclosure of temporary difference, unused tax losses and unused tax credits [line items] Disclosure of temporary difference, unused tax losses and unused tax credits [line items] Functional and presentation currency Description of accounting policy for functional currency [text block] Document Annual Report Document Annual Report Cash equivalents Cash equivalents Disclosure of detailed information about business combination [abstract] Journey Journey [Member] Journey Shares issued through common share purchase agreement - net of share issuance costs (in shares) Number Of Shares Issued, Net Of Issuance Costs Number Of Shares Issued, Net Of Issuance Costs Major items causing the income tax rate to differ from the Canadian statutory rate Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates [Table Text Block] Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates Maximum Maximum [Member] Options expired Increase (Decrease) Through Share Options Expired In Share Based Payment Award, Equity Increase (Decrease) Through Share Options Expired In Share Based Payment Award, Equity Cash Cash Disclosure of detailed information about property, plant and equipment [table] Disclosure of detailed information about property, plant and equipment [table] Share Options, Vesting, First Tranche Share Options, Vesting, First Tranche [Member] Share Options, Vesting, First Tranche Option Expiration Period Twenty One Option Expiration Period Twenty One [Member] Option Expiration Period Twenty One Equipment Description of accounting policy for property, plant and equipment [text block] Current Fiscal Year End Date Current Fiscal Year End Date Statistical Measurement [Axis] Statistical Measurement [Axis] Effect of foreign exchange Increase (decrease) through net exchange differences, intangible assets and goodwill GENERAL AND ADMINISTRATIVE EXPENSES Disclosure of general and administrative expense [text block] Disclosure of non-adjusting events after reporting period [table] Disclosure of non-adjusting events after reporting period [table] Number of shares acquired upon exercise of warrant (in shares) Number Of Shares Acquired Upon Exercise Of Warrant In Share-Based Payment Arrangement Number Of Shares Acquired Upon Exercise Of Warrant In Share-Based Payment Arrangement Share Options, Vesting, Fourth Tranche Share Options, Vesting, Fourth Tranche [Member] Share Options, Vesting, Fourth Tranche Ratio of common shares issued Ratio Of Common Shares Issued To Every One Share Of Subsidiary Outstanding Ratio Of Common Shares Issued To Every One Share Of Subsidiary Outstanding Goodwill Goodwill [member] Business combinations [axis] Business combinations [axis] Annual Information Form Annual Information Form Income Statement Location [Domain] Income Statement Location [Domain] Income Statement Location [Domain] Option Expiration Period Twenty Two Option Expiration Period Twenty Two [Member] Option Expiration Period Twenty Two Option Expiration Period Two Option Expiration Period Two [Member] Option Expiration Period Two Accounting Policies [Abstract] Accounting Policies [Abstract] June 15, 2030 Warrant Expiration Period Three [Member] Warrant Expiration Period Three RIGHT-OF-USE ASSETS AND LEASE LIABILITIES Disclosure Of Leases And Right-Of-Use Assets [Text Block] Disclosure Of Leases And Right-Of-Use Assets Entity Interactive Data Current Entity Interactive Data Current Deficit Deficit Retained earnings Payments for share issue costs Payments for share issue costs Ownership [Axis] Ownership [Axis] Weighted average fair value at measurement date, share options granted Estimated grant date fair value Weighted average fair value at measurement date, share options granted Option Expiration Period Thirty Six Option Expiration Period Thirty Six [Member] Option Expiration Period Thirty Six Canada CANADA Schedule of intangible assets Disclosure of detailed information about intangible assets [text block] Corporate information and statement of IFRS compliance [abstract] Intangible assets Balance Balance Intangible assets other than goodwill Carrying amount [member] Carrying amount [member] Classes of financial assets [axis] Classes of financial assets [axis] Categories of financial liabilities [domain] Categories of financial liabilities [domain] Option Expiration Period Nine Option Expiration Period Nine [Member] Option Expiration Period Nine Classes of share capital [axis] Classes of share capital [axis] Additions Additions other than through business combinations, intangible assets other than goodwill New standards and interpretations not yet adopted Disclosure of initial application of standards or interpretations [text block] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Currency translation Description of accounting policy for foreign currency translation [text block] Classes of property, plant and equipment [domain] Classes of property, plant and equipment [domain] Schedule of General and Administrative Expenses Disclosure of attribution of expenses by nature to their function [text block] Current Current liabilities [abstract] Share capital Issued capital Goodwill Balance at beginning of period Balance at end of period Goodwill Convertible Debentures Convertible Debentures [Member] Convertible Debentures Option Expiration Period Eleven Option Expiration Period Eleven [Member] Option Expiration Period Eleven Types of share-based payment arrangements Types of share-based payment arrangements [domain] Interest rate risk, term Interest Rate Risk, Term Interest Rate Risk, Term Statement of compliance Statement of IFRS compliance [text block] Payments Payments Of Lease Liabilities Payments Of Lease Liabilities Option Expiration Period One Option Expiration Period One [Member] Option Expiration Period One Auditor Firm ID Auditor Firm ID TOTAL ASSETS Assets Schedule Of Research Expenses Schedule Of Research Expenses [Table Text Block] Schedule Of Research Expenses Reconciliation of changes in intangible assets and goodwill [abstract] Reconciliation of changes in intangible assets and goodwill [abstract] At-the-market offering - net of share issuance costs Increase (Decrease) Through Share Offering, Equity Increase (Decrease) Through Share Offering, Equity Reconciliation of number of shares outstanding [abstract] Reconciliation of number of shares outstanding [abstract] Proceeds on issuance of common shares, net Proceeds from issuing shares Share issuance costs Share Issuance Costs [Member] Share Issuance Costs Number of granted patents Number Of Granted Patents Number Of Granted Patents Expected dividend yield Expected dividend as percentage, share options granted August 2023 compensation common share warrant August 2023 Compensation Common Share Warrant [Member] August 2023 Compensation Common Share Warrant Disclosure of detailed information about intangible assets [line items] Disclosure of detailed information about intangible assets [line items] Option Expiration Period Twenty Nine Option Expiration Period Twenty Nine [Member] Option Expiration Period Twenty Nine Net deferred tax assets Deferred tax assets Capital Management [Abstract] Capital Management [Abstract] Major ordinary share transactions Major ordinary share transactions [member] Gain on derecognition of lease liability Gain on derecognition Gain (Loss) On Derecognition of Lease Liability Gain (Loss) On Derecognition of Lease Liability Share-based compensation Description of accounting policy for share-based payment transactions [text block] Foreign currency translation gain Gains (losses) on exchange differences on translation of foreign operations, before tax Debt instrument, annual interest rate Debt Instrument, Guaranteed Interest Payable, Annual Rate Debt Instrument, Guaranteed Interest Payable, Annual Rate Classes of financial assets [domain] Classes of financial assets [domain] Provisions Description of accounting policy for provisions [text block] Option Expiration Period Thirty Four Option Expiration Period Thirty Four [Member] Option Expiration Period Thirty Four Entity Address, State or Province Entity Address, State or Province Cybin US Cybin US [Member] Cybin US Change in unrecognized deferred tax assets Tax Effect Of Change In Deferred Tax Assets Tax Effect Of Change In Deferred Tax Assets Impairment loss Impairment loss recognised in profit or loss, goodwill Cash acquired on acquisition Cash and cash equivalents in subsidiary or businesses acquired or disposed Intangible Assets [Abstract] Intangible Assets [Abstract] Convertible Debenture Private Placement Convertible Debenture Private Placement [Member] Convertible Debenture Private Placement Share Options, Vesting, Second Tranche Share Options, Vesting, Second Tranche [Member] Share Options, Vesting, Second Tranche Debt instrument, guaranteed interest payable Debt Instrument, Guaranteed Interest Payable, Rate Debt Instrument, Guaranteed Interest Payable, Rate Total Key management personnel compensation Option Expiration Period Six Option Expiration Period Six [Member] Option Expiration Period Six Option Expiration Period Four Option Expiration Period Four [Member] Option Expiration Period Four Decrease in interest rate generated on cash Interest Rate Risk, Increase (Decrease) In Interest Rate Generated On Cash Interest Rate Risk, Increase (Decrease) In Interest Rate Generated On Cash OTHER COMPREHENSIVE LOSS Other comprehensive income [abstract] Basic loss per share for the year (in dollars per share) Basic earnings (loss) per share Business development Business Development Expense Business Development Expense Working capital Working Capital Working Capital Option Expiration Period Thirty Two Option Expiration Period Thirty Two [Member] Option Expiration Period Thirty Two Warrants exercised Increase (decrease) through exercise of warrants, equity Number of shares issued upon conversion of convertible instruments (in shares) Number of Shares Issued Upon Conversion of Convertible Instruments Number of Shares Issued Upon Conversion of Convertible Instruments Classes of financial liabilities [domain] Classes of financial liabilities [domain] EXPENSES Expenses by nature [abstract] Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] Minimum Minimum [Member] Foreign currency rate Closing foreign exchange rate Intangible assets other than goodwill Intangible assets other than goodwill [member] FINANCING ACTIVITIES Cash flows from (used in) financing activities [abstract] Weighted average exercise price of share options granted in share-based payment arrangement Weighted average exercise price of share options granted in share-based payment arrangement Schedule of equipment Disclosure of detailed information about property, plant and equipment [text block] Summary of warrants Disclosure of number and weighted average exercise prices of other equity instruments [text block] United Kingdom UNITED KINGDOM NET LOSS FOR THE YEAR Net loss for the year Net loss Net loss Profit (loss) Number of common shares held in escrow (in shares) Number of Common Shares Held In Escrow Number of Common Shares Held In Escrow Other current assets Adjustments for decrease (increase) in other current assets Total allocation of purchase price Identifiable assets acquired (liabilities assumed) Option Expiration Period [Domain] Option Expiration Period [Domain] Option Expiration Period [Domain] Ownership Proportion of ownership interest in subsidiary Currency [Axis] Currency [Axis] Disclosure of nature and extent of risks arising from financial instruments [table] Disclosure of nature and extent of risks arising from financial instruments [table] Option Expiration Period Twenty Six Option Expiration Period Twenty Six [Member] Option Expiration Period Twenty Six Cash flows used in operating activities before net changes in non-cash working capital items Cash flows from (used in) operations before changes in working capital Prepaid expenses Adjustments for decrease (increase) in prepaid expenses Classes of share capital [domain] Classes of share capital [domain] Disclosure Of Non-Capital Losses Expiration [Table] Disclosure Of Non-Capital Losses Expiration [Table] Disclosure Of Non-Capital Losses Expiration [Table] Option Expiration Period Three Option Expiration Period Three [Member] Option Expiration Period Three Granted to consultants Granted To Consultants [Member] Granted To Consultants Shares issued on Adelia milestones (in shares) Number of Shares Issued Through Contingent Consideration, Equity Number of Shares Issued Through Contingent Consideration, Equity Disclosure of detailed information about business combination Disclosure of detailed information about business combination [text block] Research Research Component [Member] Research Component Exercise price of other equity instruments (in CAD/USD per share) Exercise Price of Other Equity Instruments in Share-based Payment Arrangement Exercise Price of Other Equity Instruments in Share-based Payment Arrangement Foreign currency translation differences for foreign operations Unrealized gain (loss) on translation of foreign operations Other comprehensive income, net of tax, exchange differences on translation of foreign operations Impact of 10% change in foreign currency rate Risk exposure associated with instruments sharing characteristic Unexercised stock options in subsidiary, compensation for cancellation (in CAD per share) Unexercised Stock Options In Subsidiary, Compensation For Cancellation Unexercised Stock Options In Subsidiary, Compensation For Cancellation Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table] Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table] Number of share options exercisable in share-based payment arrangement Number of options exercisable (in shares) Number of share options exercisable in share-based payment arrangement CORPORATE INFORMATION Disclosure of basis of consolidation [text block] CONTRACTS, COMMITMENTS AND CONTINGENCIES Disclosure of commitments and contingent liabilities [text block] Option Expiration Period Twenty Five Option Expiration Period Twenty Five [Member] Option Expiration Period Twenty Five Option Expiration Period Eighteen Option Expiration Period Eighteen [Member] Option Expiration Period Eighteen Warrants Warrants [member] Number of options vested (in shares) Number Of Share Options Vested In Share-Based Payment Arrangement Number Of Share Options Vested In Share-Based Payment Arrangement Exercise price, share options granted (in CAD per share) Exercise price (in CAD per share) Exercise price, share options granted Acquisition from Small Pharma Acquisitions through business combinations, intangible assets and goodwill Number of other equity instruments exercisable in share-based payment arrangement (in shares) Warrants exercisable (in shares) Number of other equity instruments exercisable in share-based payment arrangement Contributed surplus Share premium [member] Disclosure of Financial Assets and Liabilities [Table] Disclosure of Financial Assets and Liabilities [Table] Disclosure of Financial Assets and Liabilities [Table] Debt instruments issued Debt instruments issued Disclosure of reconciliation of changes in goodwill [line items] Disclosure of reconciliation of changes in goodwill [line items] Non-capital loss carryforwards - Canada Unused tax losses [member] Option Expiration Period Twenty Eight Option Expiration Period Twenty Eight [Member] Option Expiration Period Twenty Eight Converted into Common Shares (in shares) Increase (Decrease) Through Conversion of Convertible Instruments, Equity, Shares Increase (Decrease) Through Conversion of Convertible Instruments, Equity, Shares MATERIAL ACCOUNTING POLICIES AND BASIS OF PREPARATION Disclosure of material accounting policy information [text block] Loss Carryforward Expiration [Domain] Loss Carryforward Expiration [Domain] Loss Carryforward Expiration [Domain] Useful life of equipment Useful life measured as period of time, property, plant and equipment Investor relations and Marketing media Investor Relations, Sales and Marketing Expense Investor Relations, Sales and Marketing Expense Accumulated other comprehensive loss Accumulated other comprehensive income Exercise price (in USD per share) Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted Valuation allowance Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Valuation Allowance Disclosure of temporary difference, unused tax losses and unused tax credits [table] Disclosure of temporary difference, unused tax losses and unused tax credits [table] Useful life of intangible assets Useful life measured as period of time, intangible assets other than goodwill 2042 2042 [Member] 2042 Disclosure of non-adjusting events after reporting period [line items] Disclosure of non-adjusting events after reporting period [line items] Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement (in CAD per share) Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement INTANGIBLE ASSETS Disclosure of intangible assets [text block] Property, Plant and Equipment1 [Abstract] Property, Plant and Equipment [Abstract] Address Type [Domain] Address Type [Domain] Financial assets, measured at fair value: Financial assets at fair value through other comprehensive income, category [member] Option Expiration Period Thirty One Option Expiration Period Thirty One [Member] Option Expiration Period Thirty One Option Expiration Period Nineteen Option Expiration Period Nineteen [Member] Option Expiration Period Nineteen COMMITMENTS [Table] COMMITMENTS [Table] COMMITMENTS [Table] Office and administration Occupancy expense Income Taxes [Abstract] Income Taxes [Abstract] Classes Of Debt Instruments [Axis] Classes Of Debt Instruments [Axis] Classes Of Debt Instruments Audit Information [Abstract] Audit Information [Abstract] Additions Additions to right-of-use assets Classes of property, plant and equipment [axis] Classes of property, plant and equipment [axis] Schedule of remuneration of key management personnel Disclosure of transactions between related parties [text block] Estimated grant date fair value Weighted average fair value at measurement date, other equity instruments granted INVESTING ACTIVITIES Cash flows from (used in) investing activities [abstract] Local Phone Number Local Phone Number Loss carryforwards Deferred tax liability (asset) Lease payments Payments Payments of lease liabilities, classified as financing activities Acquisition of Small Pharma Acquisitions through business combinations, intangible assets other than goodwill Share-based Payment, Vesting Period [Domain] Share-based Payment, Vesting Period [Domain] Share-based Payment, Vesting Period [Domain] Warrants reserve Warrant reserve Net cash flows provided by financing activities Cash flows from (used in) financing activities Non-current Non-current assets [abstract] Computer equipment write-down Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment Geographical areas [axis] Geographical areas [axis] Lab Equipment Laboratory Equipment [Member] Laboratory Equipment Summary of share capital Disclosure of classes of share capital [text block] Schedule of right-of-use assets Disclosure of quantitative information about right-of-use assets [text block] SHAREHOLDERS' EQUITY Equity [abstract] Total Current Assets Current assets Loss Carryforward Expiration [Axis] Loss Carryforward Expiration [Axis] Loss Carryforward Expiration Entity Ex Transition Period Entity Ex Transition Period Preferred shares Preference shares [member] Temporary difference, unused tax losses and unused tax credits [axis] Temporary difference, unused tax losses and unused tax credits [axis] Disposals Disposals, right-of-use assets Business combinations [domain] Business combinations [domain] Liabilities assumed Financial liabilities recognised as of acquisition date Categories of financial assets [domain] Categories of financial assets [domain] Reconciliation of changes in property, plant and equipment [abstract] Reconciliation of changes in property, plant and equipment [abstract] Entity Emerging Growth Company Entity Emerging Growth Company Granted to officers and directors Granted To Officers And Directors [Member] Granted To Officers And Directors Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement Weighted Average Exercise Price Of Other Equity Instruments Issued In Share-based Payment Arrangement Number of common share purchase warrants (in shares) Number Of Common Share Purchase Warrants Number Of Common Share Purchase Warrants Entity Central Index Key Entity Central Index Key Business Contact Business Contact [Member] Reasonably possible change in risk variable, percent Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Percent Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Percent Share-based compensation Tax Effect Of Share Based Compensation Tax Effect Of Share Based Compensation License Licences [member] EQUIPMENT Disclosure of property, plant and equipment [text block] United States of America, Dollars United States of America, Dollars Disclosure of maturity analysis of operating lease payments [line items] Disclosure of maturity analysis of operating lease payments [line items] Amortization Depreciation, right-of-use assets Financial assets and liabilities Financial Assets And Liabilities Financial Assets And Liabilities Other contingent liabilities Other contingent liabilities [member] Equipment Balance at beginning of period Balance at end of period Net book value Property, plant and equipment Option Expiration Period Seven Option Expiration Period Seven [Member] Option Expiration Period Seven Cash Cash [Member] Cash IP Research & Development Intangible assets under development [member] Warrants exercised (in shares) Number Of Shares Issued Through Exercise Of Warrants, Equity Number Of Shares Issued Through Exercise Of Warrants, Equity Current Current assets [abstract] Goodwill [Abstract] Goodwill [Abstract] 2045 2045 [Member] 2045 Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Prepayment premium, if paid year one Debt Instrument, Prepayment Premium, Year One Debt Instrument, Prepayment Premium, Year One Capital markets Capital Market Expense Capital Market Expense Non-adjusting events after reporting period [domain] Non-adjusting events after reporting period [domain] Ireland IRELAND Deferred compensation Deferred compensation [Member] Deferred compensation Option Expiration Period Twenty Option Expiration Period Twenty [Member] Option Expiration Period Twenty City Area Code City Area Code Disclosure of subsidiaries [table] Disclosure of subsidiaries [table] Auditor Location Auditor Location Adelia Adelia [Member] Adelia Prepayment premium, if paid year two Debt Instrument, Prepayment Premium, Year Two Debt Instrument, Prepayment Premium, Year Two Patents Patents Copyrights, patents and other industrial property rights, service and operating rights [member] Prepaid expenses Current prepaid expenses Weighted average exercise price of share options exercisable in share-based payment arrangement Weighted average exercise price of share options exercisable in share-based payment arrangement May 14, 2029 Warrant Expiration Period Two [Member] Warrant Expiration Period Two Statement of changes in equity [table] Statement of changes in equity [table] Number of other equity instruments expired in share-based payment arrangement (in shares) Number of other equity instruments expired in share-based payment arrangement (in shares) Number of other equity instruments expired in share-based payment arrangement Disclosure Of Non-Capital Losses Expiration [Line Items] Disclosure Of Non-Capital Losses Expiration [Line Items] Disclosure Of Non-Capital Losses Expiration [Line Items] Option Expiration Period Twelve Option Expiration Period Twelve [Member] Option Expiration Period Twelve Cash, beginning of year Cash, end of year Cash and cash equivalents Financial instruments Description of accounting policy for financial instruments [text block] 2044 2044 [Member] 2044 Option Expiration Period Thirty Eight Option Expiration Period Thirty Eight [Member] Option Expiration Period Thirty Eight Expected life (in years) Other Equity Instruments Life, Other Equity Instruments Granted Other Equity Instruments Life, Other Equity Instruments Granted Classes Of Financial Assets And Liabilities [Domain] Classes Of Financial Assets And Liabilities [Domain] Classes Of Financial Assets And Liabilities [Domain] 2039 2039 [Member] 2039 Number of active patent families Number Of Active Patent Families Number Of Active Patent Families Number of subsidiaries Number Of Subsidiaries Number Of Subsidiaries Accounts payable and accrued liabilities Current accrued expenses and other current liabilities Euro Member Countries, Euro Euro Member Countries, Euro Non-capital losses Non-Capital Loss Carryforward Non-Capital Loss Carryforward Threshold percentage of stock price trigger Debt Instrument, Convertible Debenture, Threshold Percentage of Stock Price Trigger Debt Instrument, Convertible Debenture, Threshold Percentage of Stock Price Trigger TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Equity and liabilities Impairment of long-lived assets Description of accounting policy for impairment of assets [text block] Option Expiration Period Twenty Three Option Expiration Period Twenty Three [Member] Option Expiration Period Twenty Three Effect of exchange on unbooked deferred tax assets Increase (decrease) through net exchange differences, deferred tax liability (asset) Unobservable inputs [domain] Unobservable inputs [domain] Accounts receivable Trade receivables [member] Effect of foreign exchange Increase (decrease) through net exchange differences, property, plant and equipment Section 382 limitation Section 382 Limitation Section 382 Limitation Disclosure of subsidiaries [line items] Disclosure of subsidiaries [line items] Balance (in shares) Balance (in shares) Number of shares outstanding (in shares) Number of shares outstanding Warrants Description of accounting policy for warrants [text block] Accounts payable and accrued liabilities Accounts Payable And Accrued Liabilities [Member] Accounts Payable And Accrued Liabilities Inventories Description of accounting policy for measuring inventories [text block] Options Share-Based Payment Arrangement, Option [Member] Options General and administrative costs General And Administrative Expense [Member] General And Administrative Expense Accounts payable and accrued liabilities Adjustments For Increase (Decrease) In Accrued And Other Liabilities Adjustments For Increase (Decrease) In Accrued And Other Liabilities Non-capital losses expiration Disclosure Of Expiration Of Non Capital Losses [Table Text Block] Disclosure Of Expiration Of Non Capital Losses Effects of exchange rate changes on cash Effect of exchange rate changes on cash and cash equivalents Amendment Flag Amendment Flag Categories of financial assets [axis] Categories of financial assets [axis] Option Expiration Period Twenty Seven Option Expiration Period Twenty Seven [Member] Option Expiration Period Twenty Seven Number of common shares (in shares) Number of Common Shares Number of Common Shares OPERATING ACTIVITIES Cash flows from (used in) operating activities [abstract] Entity Registrant Name Entity Registrant Name Interest accretion Interest expense on lease liabilities Options Reserve of share-based payments [member] August 20, 2030 Warrant Expiration Period Four [Member] Warrant Expiration Period Four COMMITMENTS [Line Items] COMMITMENTS [Line Items] COMMITMENTS [Line Items] Critical Accounting Estimates and Judgements [Abstract] Critical Accounting Estimates and Judgements 2037 2037 [Member] 2037 United Kingdom, Pounds United Kingdom, Pounds Categories of financial liabilities [axis] Categories of financial liabilities [axis] Share consolidation, new shares issued (in shares) Ordinary Shares, Consolidation, New Shares Issued Ordinary Shares, Consolidation, New Shares Issued TOTAL EXPENSES Operating expense Payroll, consulting and benefits Employee benefits expense Geographical [Domain] Geographical [Domain] Effect of foreign exchange Effect Of Foreign Exchange, Right Of Use Assets Effect Of Foreign Exchange, Right Of Use Assets Effect of foreign exchange Increase (decrease) through net exchange differences, intangible assets other than goodwill Income tax recovery Tax expense (income) Entity Address, Postal Zip Code Entity Address, Postal Zip Code Title of 12(b) Security Title of 12(b) Security Class B Shares Class B Shares [Member] Class B Shares Classes of intangible assets other than goodwill [axis] Classes of intangible assets other than goodwill [axis] Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Net increase (decrease) in cash Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Risk-free interest rate Risk free interest rate, share options granted Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement (in CAD per share) Weighted average of exercisable price (in CAD per share) Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement Loss per share Description of accounting policy for earnings per share [text block] Termination penalty payment Payment For Termination Penalty, Lease Liability Payment For Termination Penalty, Lease Liability Purchase of equipment and intangible assets Purchase Of Property, Plant, Equipment And Intangible Assets, Classified As Investing Activities Purchase Of Property, Plant, Equipment And Intangible Assets, Classified As Investing Activities Warrants Warrant reserve [member] Vesting [Axis] Share-based Payment, Vesting Period [Axis] Share-based Payment, Vesting Period Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement RELATED PARTY TRANSACTIONS AND BALANCES Disclosure of related party [text block] Maximum affiliate ownership percentage Debt Instrument, Convertible Debenture, Maximum Affiliate Ownership Percentage Debt Instrument, Convertible Debenture, Maximum Affiliate Ownership Percentage Options reserve Reserve of share-based payments Auditor Name Auditor Name Share price (in CAD per share) Weighted average share price, share options granted Additions Additions other than through business combinations, property, plant and equipment Disclosure of detailed information about property, plant and equipment [line items] Disclosure of detailed information about property, plant and equipment [line items] All Currencies [Domain] All Currencies [Domain] Advancement of development programs Advancement Of Development Programs Advancement Of Development Programs Profit or loss [abstract] Items of contingent liabilities [axis] Items of contingent liabilities [axis] Listing fees Listing Fees Expense Listing Fees Expense Basis of measurement Disclosure Of Accounting Policy For Basis Of Measurement [Policy Text Block] Disclosure Of Accounting Policy For Basis Of Measurement Classes Of Financial Assets And Liabilities [Axis] Classes Of Financial Assets And Liabilities [Axis] Classes Of Financial Assets And Liabilities CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS Disclosure of accounting judgements and estimates [text block] Weighted average number of common shares outstanding - basic (in shares) Weighted average number of ordinary shares used in calculating basic earnings per share Depreciation/Capital cost allowance differences Property, Plant And Equipment Related Temporary Differences [Member] Property, Plant And Equipment Related Temporary Differences 2036 2036 [Member] 2036 Weighted average exercise price of share options exercised in share-based payment arrangement Weighted Average Exercise Price Of Share Options Forfeited And Expired In Share-Based Payment Arrangement Weighted Average Exercise Price Of Share Options Forfeited And Expired In Share-Based Payment Arrangement Classes Of Debt Instruments [Domain] Classes Of Debt Instruments [Domain] Classes Of Debt Instruments [Domain] Ownership [Domain] Ownership [Domain] Payroll, consulting and benefits Key management personnel compensation, short-term employee benefits Number of pending patent applications Number Of Pending Patent Applications Number Of Pending Patent Applications Granted to directors Granted To Directors [Member] Granted To Directors Commitments [Abstract] Commitments [Abstract] Purchase period, term Common Shares Purchase Period, Term Common Shares Purchase Period, Term Disclosure Of Capital Structure Disclosure Of Capital Structure [Table Text Block] Disclosure Of Capital Structure Cash Cash Recognised as of Acquisition Date Cash Recognised as of Acquisition Date Intangible Assets Description of accounting policy for intangible assets other than goodwill [text block] Presentation of leases for lessee [abstract] Threshold trading days Debt Instrument, Convertible Debenture, Threshold Trading Days Debt Instrument, Convertible Debenture, Threshold Trading Days Option Expiration Period Fifteen Option Expiration Period Fifteen [Member] Option Expiration Period Fifteen Lease liabilities Current lease liabilities Lab and administration Lab And Administration Lab And Administration Share-based compensation Key management personnel compensation, share-based payment Contributed surplus Share premium Currency risk Currency risk [member] Research Total Research and development expense Net equipment Property, plant and equipment recognised as of acquisition date Research and Development expenditures R&D expenditures [Member] R&D expenditures Debt instrument, term Debt Instrument, Term Debt Instrument, Term 2040 2040 [Member] 2040 Entity Address, City or Town Entity Address, City or Town Share capital Description of accounting policy for issued capital [text block] Contractual commitments Contractual capital commitments Issued (in shares) Number of Other Equity Instruments Issued in Share-Based Payment Arrangement Number of Other Equity Instruments Issued in Share-Based Payment Arrangement Option Expiration Period [Axis] Option Expiration Period [Axis] Option Expiration Period Amortization charge Amortisation, intangible assets other than goodwill LPC Purchase Agreement LPC Purchase Agreement [Member] LPC Purchase Agreement General and administrative costs Total General and administrative expense Goodwill Description of accounting policy for goodwill [text block] Other current assets Other current assets Intellectual property Identifiable intangible assets recognised as of acquisition date Changes in equity [abstract] Changes in equity [abstract] Payroll and benefits Payroll And Benefits Payroll And Benefits Issuance of common shares as commitment fee for equity financing (in shares) Number Of Shares Issued Through Commitment Fee For Equity Financing Number Of Shares Issued Through Commitment Fee For Equity Financing Entity File Number Entity File Number Disclosure of reconciliation of changes in goodwill [table] Disclosure of reconciliation of changes in goodwill [table] Common stock shares, authorized value Common Stock Shares Authorized Value Common Stock Shares Authorized Value Taxation Description of accounting policy for income tax [text block] Share capital Issued capital [member] Share issuance costs Tax Effect Of Share Issuance Costs Tax Effect Of Share Issuance Costs Document Fiscal Year Focus Document Fiscal Year Focus Entity Address, Address Line One Entity Address, Address Line One Classes of assets [domain] Classes of assets [domain] Entity Address, Address Line Two Entity Address, Address Line Two Exercise price (in dollars per share) Exercise price of outstanding share options Document Period End Date Document Period End Date Option Expiration Period Thirty Seven And Thirty Eight Option Expiration Period Thirty Seven And Thirty Eight [Member] Option Expiration Period Thirty Seven And Thirty Eight Cash and cash equivalents Description of accounting policy for determining components of cash and cash equivalents [text block] Classes of assets [axis] Classes of assets [axis] Weighted average exercise price of share options forfeited in share-based payment arrangement (in CAD per share) Weighted average exercise price of share options forfeited in share-based payment arrangement Share-based compensation Adjustments for share-based payments Other loss Other loss Other expenses, by nature Expected annual volatility, based on comparable companies Expected Volatility, Other Equity Instruments Granted Expected Volatility, Other Equity Instruments Granted Net changes in non-cash working capital items: Adjustments For Working Capital [Abstract] Adjustments For Working Capital Deficit Retained earnings [member] Shares issued through common share purchase agreement - net of share issuance costs Issue of equity Disclosure of classes of share capital [line items] Disclosure of classes of share capital [line items] Total Non-Current Assets Non-current assets Option Expiration Period Thirty Three Option Expiration Period Thirty Three [Member] Option Expiration Period Thirty Three Granted to officers Granted To Officers [Member] Granted To Officers Number of options, beginning balance (in shares) Number of options, ending balance (in shares) Number of share options outstanding (in shares) Number of share options outstanding in share-based payment arrangement Option Expiration Period Seventeen Option Expiration Period Seventeen [Member] Option Expiration Period Seventeen COMPREHENSIVE LOSS FOR THE YEAR Comprehensive income TOTAL SHAREHOLDERS' EQUITY Balance Balance Equity Accounts receivable Adjustments for decrease (increase) in trade accounts receivable Entity Primary SIC Number Entity Primary SIC Number Disclosure of nature and extent of risks arising from financial instruments [line items] Disclosure of nature and extent of risks arising from financial instruments [line items] Significant components of deferred tax assets Disclosure of temporary difference, unused tax losses and unused tax credits [text block] Entity Current Reporting Status Entity Current Reporting Status Revenue Revenue 2040 - 2041 2040 - 2041 [Member] 2040 - 2041 TOTAL OTHER INCOME Other income November 2023 compensation common share warrant November 2023 Compensation Common Share Warrant [Member] November 2023 Compensation Common Share Warrant Class B shares converted (in shares) Number of Shares Converted Through Contingent Consideration, Equity Number of Shares Converted Through Contingent Consideration, Equity Fair value of purchaser consideration Consideration transferred, acquisition-date fair value Small Pharma Inc. ("Small Pharma") Small Pharma Inc. [Member] Small Pharma Inc. Non-deductible expenses Tax effect of expense not deductible in determining taxable profit (tax loss) Analysis of income and expense [abstract] Goodwill Goodwill recognised as of acquisition date Reconciliation of changes in intangible assets other than goodwill [abstract] Reconciliation of changes in intangible assets other than goodwill [abstract] Financial liabilities, measured at amortized cost: Financial liabilities at amortised cost, category [member]